Abortion, Threatened/drug therapy , Pregnadienediols/therapeutic use , Abortion, Habitual/drug therapy , Adult , Allylestrenol/therapeutic use , Contraceptives, Oral, Combined/administration & dosage , Contraceptives, Oral, Combined/adverse effects , Contraceptives, Oral, Combined/therapeutic use , Female , Humans , Pregnadienediols/administration & dosage , Pregnadienediols/adverse effects , Pregnancy , Pregnancy Trimester, First , Pregnancy Trimester, Second , Tablets
Conjunctivitis, Allergic/drug therapy , Quinuclidines/therapeutic use , Rhinitis, Allergic, Perennial/drug therapy , Rhinitis, Allergic, Seasonal/drug therapy , Clinical Trials as Topic , Drug Administration Schedule , Histamine H1 Antagonists/administration & dosage , Histamine H1 Antagonists/therapeutic use , Humans , Quinuclidines/administration & dosage , Serotonin Antagonists/administration & dosage , Serotonin Antagonists/therapeutic use , USSR
Dermatitis, Atopic/drug therapy , Histamine H1 Antagonists/therapeutic use , Quinuclidines/therapeutic use , Serotonin Antagonists/therapeutic use , Adolescent , Adult , Aged , Clinical Trials as Topic , Humans , Hypersensitivity, Delayed/drug therapy , Hypersensitivity, Immediate/drug therapy , Middle Aged , Time Factors
Theophylline/analogs & derivatives , Xanthinol Niacinate/pharmacology , Animals , Arteriosclerosis/drug therapy , Cats , Diabetic Angiopathies/drug therapy , Dose-Response Relationship, Drug , Drug Evaluation , Drug Evaluation, Preclinical , Hemodynamics/drug effects , Humans , Intracranial Arteriosclerosis/drug therapy , Mice , Peripheral Nervous System Diseases/drug therapy , Rats , Raynaud Disease/drug therapy , Xanthinol Niacinate/therapeutic use , Xanthinol Niacinate/toxicity
It has been established during intraperitoneal and oral administration of ethanol to white rats in a test dose of 1 g/kg that in the animals with high alcoholism motivation, the rate of alcohol elimination from blood is fairly high, while the species with low alcoholic motivation are marked by a slower ethanol elimination. In rats with high alcohol motivation, the time of ethanol anesthesia significantly exceeds that in the animals with low alcoholic motivation. The blood levels of ethanol at the moment of wake up are identical in both groups. A conclusion is made about the relationship between the elimination pattern, activity of alcohol-metabolizing enzymatic systems and predisposition to alcoholism.
Alcoholism/etiology , Ethanol/metabolism , Motivation , Administration, Oral , Alcoholism/psychology , Animals , Ethanol/administration & dosage , Ethanol/blood , Humans , Injections, Intraperitoneal , Male , Rats , Time Factors
Correlation between the dynamics of triftazine (stelazine, trifluoperazine) distribution in the brain, liver, and blood plasma of rats and the dynamics marking the development of cataleptic and antiagressive effects and also upset motor conditionation was studied. It was found that following oral administration of triftazine it slowly reaches the organs, the greatest part being adsorbed in the liver. On the contrary, of its intramuscular administration is characteristic a quicker accumulation in the organs and then the level of the neuroleptic in the brain and plasma is higher and in the liver - lower than with its oral introduction. A dissimilar dynamics of triftazine in the brain explains the difference of its pharmacological effects with diverse modes of administration. When given by mouth the content of the drug in the brain is insignificant and it rises but slowly, this being matched by a correspondingly slow development of the effects of triftazine. With the intramuscular route of introduction the neuroleptic's content in the brain rapidly reaches a high level, while its pharmacological effects are characterized by a quicker development than this is the case with its oral administration.
Trifluoperazine/metabolism , Administration, Oral , Animals , Blood/metabolism , Brain/metabolism , Injections, Intramuscular , Kinetics , Liver/metabolism , Male , Rats , Time Factors , Trifluoperazine/administration & dosage , Trifluoperazine/pharmacology
Amphetamine/pharmacology , Brain/drug effects , Caffeine/pharmacology , Piperidines/pharmacology , Potassium/metabolism , Animals , Brain/metabolism , Cell Membrane Permeability/drug effects , Cerebral Cortex/drug effects , Cerebral Cortex/metabolism , Diencephalon/drug effects , Diencephalon/metabolism , Medulla Oblongata/drug effects , Medulla Oblongata/metabolism , Mesencephalon/drug effects , Mesencephalon/metabolism , Potassium Isotopes , Rats
Adenosine Triphosphatases/metabolism , Amphetamine/pharmacology , Brain/enzymology , Caffeine/pharmacology , Microsomes/enzymology , Piperidines/pharmacology , Animals , Cerebral Cortex/enzymology , Depression, Chemical , Diencephalon/enzymology , Male , Medulla Oblongata/enzymology , Mesencephalon/enzymology , Potassium/pharmacology , Rats , Sodium/pharmacology , Stimulation, Chemical
Brain Chemistry/drug effects , Caffeine/administration & dosage , Medulla Oblongata/analysis , Motor Activity/drug effects , Motor Neurons/analysis , Potassium/analysis , Sodium/analysis , Animals , Brain Stem/analysis , Cerebral Cortex/analysis , Depression, Chemical , Male , Rats , Stimulation, Chemical
Amphetamine/pharmacology , Brain Chemistry/drug effects , Extracellular Space/analysis , Motor Activity/drug effects , Piperidines/pharmacology , Potassium/analysis , Sodium/analysis , Animals , Brain/cytology , Brain Stem/analysis , Cerebral Cortex , Depression, Chemical , Male , Medulla Oblongata/analysis , Rats , Stimulation, Chemical